Thermo Fisher Scientific Inc (TMO) Stock Analysis
Falling Knife setup
Healthcare · Diagnostics & Research
Hold if already holding. Not a fresh buy at $440.83, but acceptable to hold if already in. Reasons: Negative news sentiment (-0.67); Negative momentum.
Thermo Fisher Scientific serves pharmaceutical, biotech, academic, government, and clinical customers globally across Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products & Biopharma Services segments. With ~125,000 employees across 60+... Read more
Hold if already holding. Not a fresh buy at $440.83, but acceptable to hold if already in. Reasons: Negative news sentiment (-0.67); Negative momentum. Chart setup: Death cross, below all MAs, RSI 36, MACD bearish. Maintain position. Not compelling to add more. Score 5.2/10, moderate confidence.
Passes 7/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 65d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum. Suitability: moderate.
Recent Developments — Thermo Fisher Scientific Inc
Latest news
- Annex Advisory Services LLC Acquires 3,469 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat — MarketBeat neutral
- TMO Maintains Overweight Rating by Barclays -- Price Target Lowe - GuruFocus — GuruFocus positive
- TD Cowen Lowers Thermo Fisher (TMO) Price Target, Keeps Buy Rating - Insider Monkey — Insider Monkey neutral
- TD Cowen Lowers Thermo Fisher (TMO) Price Target, Keeps Buy Rating - Yahoo Finance — Yahoo Finance neutral
- Foresight Group Ltd Liability Partnership's Thermo Fisher Scientific Inc(TMO) Holding History - GuruFocus — GuruFocus neutral
Generated 2026-05-20T20:21:21Z.
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $440.83, but acceptable to hold if already in. Reasons: Negative news sentiment (-0.67); Negative momentum. Chart setup: Death cross, below all MAs, RSI 36, MACD bearish. Maintain position. Not compelling to add more. Target $550.40 (+24.9%), stop $422.21 (−4.4%), A.R:R 4.0:1. Score 5.2/10, moderate confidence.
Take-profit target: $550.40 (+24.8% upside). Target $550.40 (+24.9%), stop $422.21 (−4.4%), A.R:R 4.0:1. Stop-loss: $422.21.
Negative news sentiment (-0.67); Negative momentum.
Thermo Fisher Scientific Inc trades at a P/E of 24.1 (forward 16.1). TrendMatrix value score: 5.9/10. Verdict: Hold.
34 analysts cover TMO with a consensus score of 4.2/5. Average price target: $612.
What does Thermo Fisher Scientific Inc do?Thermo Fisher Scientific serves pharmaceutical, biotech, academic, government, and clinical customers globally across...
Thermo Fisher Scientific serves pharmaceutical, biotech, academic, government, and clinical customers globally across Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products & Biopharma Services segments. With ~125,000 employees across 60+ countries, it provides instruments, reagents, consumables, and outsourced biopharma development and manufacturing services.